Imagion Biosystems Limited IBXXF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.10M | -2.95M | -2.79M | -2.10M | -1.41M |
| Total Depreciation and Amortization | 4.20K | 4.90K | 5.60K | 6.70K | 7.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 865.30K | 760.30K | 656.40K | 66.40K | -528.70K |
| Change in Net Operating Assets | -485.40K | -485.40K | -485.40K | -208.60K | 68.30K |
| Cash from Operations | -2.71M | -2.67M | -2.61M | -2.23M | -1.86M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Issued | 300.00K | 150.00K | -- | 250.00K | 500.00K |
| Total Debt Repaid | -300.00K | -150.00K | -- | -21.60K | -43.20K |
| Issuance of Common Stock | 3.50M | 3.50M | 3.50M | 3.31M | 3.13M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -273.20K | -265.40K | -257.60K | -224.90K | -192.20K |
| Cash from Financing | 2.11M | 2.12M | 2.13M | 2.17M | 2.24M |
| Foreign Exchange rate Adjustments | -17.40K | -15.80K | -14.10K | -6.20K | 1.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -616.20K | -563.40K | -501.10K | -72.00K | 379.20K |